Allen Lutz
Stock Analyst at Bank of America Securities
(4.73)
# 694
Out of 5,055 analysts
633
Total ratings
62.3%
Success rate
10.7%
Average return
Main Sectors:
Stocks Rated by Allen Lutz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Reiterated: Buy | $110 | $90.39 | +21.69% | 37 | Oct 13, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Buy | $17 | $8.44 | +101.42% | 25 | Oct 12, 2026 | |
| HIMS Hims & Hers Health | Reiterated: Hold | $32 | $27.72 | +15.44% | 78 | Oct 8, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $110 | $85.56 | +28.56% | 25 | Oct 7, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $34 | $22.82 | +48.99% | 26 | Oct 7, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,050 | $976.57 | +7.52% | 42 | Oct 5, 2026 | |
| TDOC Teladoc Health | Reiterated: Buy | $11 | $5.81 | +80.72% | 82 | Sep 24, 2026 | |
| DOCS Doximity | Reiterated: Sell | $20 | $29.92 | -33.16% | 46 | Sep 23, 2026 | |
| GDRX GoodRx Holdings | Reiterated: Sell | $2.65 | $3.38 | -21.60% | 32 | Sep 15, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $38 | $26.87 | +41.42% | 25 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $40.58 | +15.82% | 7 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $89.87 | +39.09% | 58 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 | $336.17 | -1.84% | 26 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.25 → $1.3 | $0.3128 | +315.60% | 17 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.7 | $0.9854 | -28.96% | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $27.84 | +11.35% | 23 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $35.39 | - | 33 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 | $247.74 | +4.95% | 21 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.15 | n/a | 11 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $4.41 | n/a | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $41 | $0.0001 | n/a | 2 | Aug 10, 2022 |
CVS Health
Oct 13, 2026
Reiterated: Buy
Price Target: $110
Current: $90.39
Upside: +21.69%
DENTSPLY SIRONA
Oct 12, 2026
Reiterated: Buy
Price Target: $17
Current: $8.44
Upside: +101.42%
Hims & Hers Health
Oct 8, 2026
Reiterated: Hold
Price Target: $32
Current: $27.72
Upside: +15.44%
Henry Schein
Oct 7, 2026
Reiterated: Buy
Price Target: $110
Current: $85.56
Upside: +28.56%
Envista Holdings
Oct 7, 2026
Reiterated: Buy
Price Target: $34
Current: $22.82
Upside: +48.99%
McKesson
Oct 5, 2026
Reiterated: Buy
Price Target: $1,050
Current: $976.57
Upside: +7.52%
Teladoc Health
Sep 24, 2026
Reiterated: Buy
Price Target: $11
Current: $5.81
Upside: +80.72%
Doximity
Sep 23, 2026
Reiterated: Sell
Price Target: $20
Current: $29.92
Upside: -33.16%
GoodRx Holdings
Sep 15, 2026
Reiterated: Sell
Price Target: $2.65
Current: $3.38
Upside: -21.60%
Waystar Holding
Sep 15, 2026
Reiterated: Buy
Price Target: $38
Current: $26.87
Upside: +41.42%
Sep 1, 2026
Reiterated: Buy
Price Target: $47
Current: $40.58
Upside: +15.82%
Aug 28, 2026
Reiterated: Buy
Price Target: $125
Current: $89.87
Upside: +39.09%
Aug 12, 2026
Reiterated: Hold
Price Target: $330
Current: $336.17
Upside: -1.84%
Aug 11, 2026
Reiterated: Sell
Price Target: $2.25 → $1.3
Current: $0.3128
Upside: +315.60%
Aug 11, 2026
Reiterated: Sell
Price Target: $0.7
Current: $0.9854
Upside: -28.96%
Aug 7, 2026
Reiterated: Buy
Price Target: $31
Current: $27.84
Upside: +11.35%
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.39
Upside: -
Jul 20, 2026
Reiterated: Buy
Price Target: $260
Current: $247.74
Upside: +4.95%
Aug 5, 2024
Rated: Hold
Price Target: n/a
Current: $12.15
Upside: n/a
Jun 20, 2023
Reiterated: Hold
Price Target: $12
Current: $4.41
Upside: n/a
Aug 10, 2022
Reiterated: Hold
Price Target: $50 → $41
Current: $0.0001
Upside: n/a